TCT 2015: Abbott's Bioresorbable Scaffold Matches Metal DES But Longer-Term Data Is Needed
This article was originally published in The Gray Sheet
The results of the ABSORB III trial were presented Oct. 12 at TCT. Abbott's fully bioresorbable scaffold met its endpoint, but more questions need to be answered, cardiologists say.
Register for our free email digests: